Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

LOGIN TO START A DISCUSSION
Filter by Molecular Oncology Tumor Board
Molecular Oncology Tumor Board
ASCO University
Dec 02, 2015 10:12 AM
Read more to answer the following questions: 1) Who should get routine molecular testing at diagnosis for NSCLC and what tests should be performed? 2)  Given this patient’s age and smoking history are you surprised at the finding of an EGFR mutation? 3) What is the most appropriate initial...
Molecular Oncology Tumor Board
ASCO University
Nov 04, 2015 10:35 AM
Read more to answer the following questions: 1) Does this tumor have a variant morphology and is it significant clinically? 2.) What are the diagnostic/staging studies at this point? 3.) What are treatment options for this patient? 4.) Which tumor gene mutational analysis, if any, might aid in...
Molecular Oncology Tumor Board
ASCO University
Oct 14, 2015 10:22 AM
Read more to answer the following questions: 1. In general, would you be more inclined to offer a targeted therapy regimen or an immune therapy regimen? 2. If a BRAF-targeted therapy approach is selected, what therapeutic options are the most appropriate? 3. If an immune-targeted therapy approach...
Molecular Oncology Tumor Board
ASCO University
Sep 09, 2015 9:57 AM
Read more to answer the following questions: 1) What is the differential diagnosis of skin rashes that precede or accompany a diagnosis of acute myeloid leukemia?  What particular dermatological condition does this patient have?  How would you treat it? 2) What is the prognostic significance of the...
Molecular Oncology Tumor Board
ASCO University
Aug 12, 2015 9:39 AM
Read more to answer the following questions: 1) What tumor types should be considered in the differential diagnosis of a CK7+ CK20- CUP? 2)Could you have performed additional immunohistochemical stains to try to determine the site of origin? 3) Is EML4-ALK fusion unique to lung adenocarcinomas? 4) ...

Pages